Elo Mutual Pension Insurance Co Purchases 8,729 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Elo Mutual Pension Insurance Co increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,008 shares of the company’s stock after acquiring an additional 8,729 shares during the period. Elo Mutual Pension Insurance Co’s holdings in GE HealthCare Technologies were worth $3,675,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of GEHC. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of GE HealthCare Technologies by 10.9% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 746,595 shares of the company’s stock valued at $60,116,000 after acquiring an additional 73,578 shares in the last quarter. Korea Investment CORP raised its position in shares of GE HealthCare Technologies by 58.1% in the 4th quarter. Korea Investment CORP now owns 294,622 shares of the company’s stock worth $23,034,000 after acquiring an additional 108,300 shares in the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its position in shares of GE HealthCare Technologies by 24.6% during the fourth quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 46,463 shares of the company’s stock valued at $3,632,000 after buying an additional 9,166 shares during the last quarter. Graney & King LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth $75,000. Finally, Trust Investment Advisors increased its holdings in shares of GE HealthCare Technologies by 55.5% during the fourth quarter. Trust Investment Advisors now owns 8,350 shares of the company’s stock valued at $653,000 after acquiring an additional 2,979 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 2.0 %

Shares of GE HealthCare Technologies stock opened at $80.01 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The stock has a market cap of $36.59 billion, a PE ratio of 18.48, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a 50-day moving average of $86.70 and a two-hundred day moving average of $85.86. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s payout ratio is 3.23%.

Analyst Upgrades and Downgrades

GEHC has been the subject of several research analyst reports. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Finally, Citigroup raised their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.